Skip to content

T · 3405.T · CHEMICALS

Kuraray Co., Ltd. (3405.T) intrinsic value and stock valuation

$1,748.50as of 2026-11-21 · Mkt cap 481.17B

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Kuraray Co., Ltd. DCF and intrinsic value

InvestorsCraft values 3405.T with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from 3405.T’s statements →

Kuraray Co., Ltd. Graham Number

Graham Number: $1,126.39d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Basic Materials · Chemicals Tokyo 100-0004 kuraray.co.jp

How the business is doing

Fiscal 2011–2025, USD

Revenue
$808.4B+8.3% 5y CAGRd
20112025
Net income
$7.47B+23.8% 5y CAGRd
20112025
Free cash flow
$936M
20112025
Total equity
$755.2B+7.9% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$808.4B$826.9B$780.9B$756.4B$629.4B
Operating income$58.9B$85.1B$75.5B$87.1B$72.3B
Net income$7.47B$31.7B$42.4B$54.3B$37.3B
EPSd$23.6M$96.3M$126.7M$161M$108.2M
Operating cash flow$98.6B$138.3B$129.3B$51.7B$78.2B
Capital expenditure-$-97.66B-$-75.78B-$-60.55B-$-72.66B-$-70.18B
Free cash flow$936M$62.5B$68.7B-$-20.93B$8.04B
Total assets$1.3T$1.29T$1.25T$1.22T$1.09T
Total debt$284.9B$287.3B$320.2B$357.5B$327.5B
Net debt$180.8B$169.3B$189.1B$233.8B$175.6B
Total equity$755.2B$781.8B$736.2B$668.5B$579.6B
Cash and short-term investments$108.3B$121.7B$134.6B$128.6B$155.8B
Income statement
20252024202320222021
Revenue$808.4B$826.9B$780.9B$756.4B$629.4B
Cost of revenue$561.9B$559.1B$539.6B$513.1B$423.9B
Gross profit$246.5B$267.7B$241.4B$243.3B$205.4B
Research and development expenses$0.00$25.7B$24.4B$22.7B$20.8B
Selling, general and administrative expenses$187.6B$157B$141.4B$133.5B$112.3B
Other expenses$0.00$0.00$0.00$0.00$0.00
Operating expenses$187.6B$182.7B$165.9B$156.1B$133.2B
Cost and expenses$749.6B$741.8B$705.5B$669.2B$557.1B
Interest income$2.26B$3.42B$1.84B$450M$141M
Interest expense$2.81B$2.74B$2.82B$1.46B$1.63B
Depreciation and amortization$84.7B$85.3B$77.2B$65.5B$59B
Ebitda$143.6B$170.3B$152.6B$152.6B$131.3B
Operating income$58.9B$85.1B$75.5B$87.1B$72.3B
Total other income/expenses, net-$-39.06B-$-31.91B-$-14.2B-$-9.14B-$-13.56B
Income before tax$19.8B$53.2B$61.3B$78B$58.7B
Income tax expense$14.8B$22B$19B$22.4B$20.3B
Net income$7.47B$31.7B$42.4B$54.3B$37.3B
Weighted average shares outstanding$316.3M$329.3M$334.7M$337.1M$344M
Weighted average diluted shares outstanding$316.4M$329.5M$335M$337.3M$344.3M
Balance sheet
20252024202320222021
Cash and short-term investments$108.3B$121.7B$134.6B$128.6B$155.8B
Net receivables$177.4B$165.6B$161B$156.5B$135.3B
Inventory$268.4B$256.8B$228B$225B$157.3B
Total current assets$578.4B$565.3B$551.7B$533.9B$470.2B
Property, plant and equipment, net$549.1B$540.4B$527B$512.6B$455.3B
Goodwill and intangible assets$110.6B$115.9B$120.5B$121.5B$114.1B
Long-term investments$23.5B$29.9B$24B$23.3B$25.8B
Total non-current assets$725.1B$726B$702.8B$687.6B$620.8B
Total assets$1.3T$1.29T$1.25T$1.22T$1.09T
Accounts payable$58.5B$59.6B$49.1B$52.7B$49.6B
Short-term debt$88.7B$58.5B$69.8B$89.2B$91.4B
Deferred revenue$0.00$3.43B$9.25B$5.98B$0.00
Total current liabilities$228.2B$198.2B$200.6B$221.3B$219.5B
Long-term debt$196.2B$228.9B$250.5B$268.3B$236.1B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$320.1B$311.2B$317.8B$331.7B$291.9B
Capital lease obligations$0.00$36.6B$33.1B$28.8B$18.2B
Total liabilities$548.3B$509.4B$518.3B$553B$511.4B
Common stock$89B$89B$89B$89B$89B
Retained earnings$386.9B$396.8B$426.3B$399.9B$359.9B
Accumulated other comprehensive income (loss)$212.7B$192.9B$137.9B$96.8B$40.3B
Total equity$755.2B$781.8B$736.2B$668.5B$579.6B
Total investments$27.7B$33.5B$27.5B$28.1B$29.6B
Total debt$284.9B$287.3B$320.2B$357.5B$327.5B
Net debt$180.8B$169.3B$189.1B$233.8B$175.6B
Cash flow statement
20252024202320222021
Net income$7.47B$31.7B$42.4B$54.3B$37.3B
Depreciation and amortization$84.7B$85.3B$77.2B$65.5B$59B
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital-$-11.82B-$-466M$17.2B-$-69.31B-$-5.35B
Accounts receivable-$-8.85B$2.2B$2.11B-$-12.5B-$-13.44B
Inventory-$-6.33B-$-17.26B$8.36B-$-54.72B-$-17.54B
Accounts payable-$-1.33B$6.24B-$-5.12B$691M$12.2B
Net cash provided by operating activities$98.6B$138.3B$129.3B$51.7B$78.2B
Investments in property, plant and equipment-$-97.66B-$-75.78B-$-60.55B-$-72.66B-$-70.18B
Acquisitions, net$0.00$0.00$214M$1.12B$1.91B
Net cash used for investing activities-$-98.13B-$-76.01B-$-63.15B-$-68.12B-$-63.78B
Common stock issued$0.00$0.00$0.00$0.00$82M
Common stock repurchased-$-30B-$-20B-$-4M-$-10B-$-2M
Dividends paid-$-17.37B-$-17.29B-$-16.07B-$-13.91B-$-13.41B
Net cash used for financing activities-$-16.31B-$-82.5B-$-64.96B-$-12.56B-$-49.27B
Net change in cash-$-17.59B-$-11.97B$6.05B-$-23.87B-$-30.6B
Cash at end of period$104.1B$121.7B$133.7B$127.6B$151.5B
Operating cash flow$98.6B$138.3B$129.3B$51.7B$78.2B
Capital expenditure-$-97.66B-$-75.78B-$-60.55B-$-72.66B-$-70.18B
Free cash flow$936M$62.5B$68.7B-$-20.93B$8.04B
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Kuraray Co., Ltd.

        Kuraray Co., Ltd. engages in the production and sale of resins, chemicals, fibers, activated carbon, and high-performance membranes and systems worldwide. The Vinyl Acetate segment manufactures and markets functional resins and films, including PVA, PVB and EVAL. The Isoprene segment engages in the manufacture and marketing of SEPTON thermoplastic elastomer, isoprene-related products, and GENESTAR. The Functional Materials segment manufactures and markets methacrylic resin, medical products, and carbon materials. The Fibers and Textiles segment manufactures and sells synthetic fibers and textiles, CLARINO manmade leather, non-woven fabrics, and other products. The Trading segment mainly processes and sells synthetic fibers and manmade leathers. The company was founded in 1926 and is headquartered in Tokyo, Japan.

        CEO
        Hitoshi Kawahara
        Employees
        11.94K
        Beta
        0.05

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Kuraray Co., Ltd. (3405.T)?

        InvestorsCraft does not currently publish an intrinsic value for 3405.T. How the IC value is calculated.

        Is 3405.T undervalued?

        InvestorsCraft does not publish an undervaluation signal for 3405.T at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.